Ivermectin topical - Galderma

Drug Profile

Ivermectin topical - Galderma

Alternative Names: CD 5024; Soolantra

Latest Information Update: 21 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Galderma
  • Class Antiparasitics; Macrolides
  • Mechanism of Action Chloride channel agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Rosacea
  • Phase II Acne vulgaris; Atopic dermatitis

Most Recent Events

  • 17 Jul 2017 Galderma initiates litigation against Perrigo over ANDA submission in USA
  • 26 Jun 2017 Galderma completes phase II trials in Atopic dermatitis in Canada (NCT03250624)
  • 02 Nov 2016 Galderma completed a phase II trial in Acne vulgaris in Germany (Topical) (EudraCT2016-000063-16)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top